Home › Trial NCT00798213
SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)
- Trial IDNCT00798213
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorMerck Sharp & Dohme LLC
- Enrollment29
- Start date2009-01
- ConditionsLeukemia, Myeloid, Acute · Lymphoblastic Leukemia, Acute
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.